Home LiteratureArticle Details
PMID: 9314551 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Required early complement activation in contact sensitivity with generation of local C5-dependent chemotactic activity, and late T cell interferon gamma: a possible initiating role of B cells.

The Journal of experimental medicine ·Vol. 186 ·No. 7 ·1997-10-06 ·Pages 1015-26

Tsuji RF, Geba GP, Wang Y, Kawamoto K, Matis LA, Askenase PW

Abstract

Complement (C) is an important component of innate immunity, and was also shown recently to participate in induction of acquired B cell humoral immunity. In this study, we present evidence that C also participates in acquired T cell immunity. We found that C was involved in early events of the efferent elicitation phase of contact sensitivity (CS), and delayed-type hypersensitivity (DTH). Thus, CS and DTH were inhibited by administration of a C-blocker, soluble recombinant C receptor-1 (sCR1), when given 30 min before, but not 3 h after local antigen challenge. Among C components, local C5 were thought crucial to elicitation of CS, since local administration of anti-C5 monoclonal antibodies or locally injected C-depleting cobra venom factor also inhibited CS and DTH. These findings were consistent with our previous finding of the importance of C5 for CS elicitation, using congenitally C5-deficient mice. To dissect the mechanism of C dependence in CS, we demonstrated that locally increased early macrophage chemotactic activity (probably C5a) in evolving CS skin extracts, as well as late elaboration of IFN-gamma, were both inhibited by anti-C treatment. In addition, histological analysis showed that leukocyte recruitment into CS ear sites was similarly C-dependent. Furthermore, an initiating role of B cell-derived C-fixing immunoglobulin was suggested by demonstration of impaired CS responses in B cell-deficient mice. In summary, these results suggest that C was activated locally, perhaps via a B cell product, in an important early component of the stepwise events necessary to elicit CS, leading to local production of C5-dependent macrophage chemotactic activity and later IFN-gamma, and subsequently leading to cell infiltration, for development of T cell-dependent CS.

MeSH Terms
Animals Antibodies, Monoclonal/immunology B-Lymphocytes/immunology Chemotactic Factors/biosynthesis Chemotaxis Complement Activation/immunology Complement C5/immunology,metabolism Complement Inactivator Proteins/immunology,pharmacology Dermatitis, Contact/immunology Elapid Venoms/pharmacology Female Hypersensitivity, Delayed/immunology Interferon-gamma/biosynthesis Macrophages/physiology Mice Mice, Inbred Strains Receptors, Complement/immunology Recombinant Proteins/pharmacology Skin/immunology T-Lymphocytes/immunology,metabolism
Chemicals
Antibodies, Monoclonal Chemotactic Factors Complement C5 Complement Inactivator Proteins Elapid Venoms Receptors, Complement Recombinant Proteins cobra venom factor soluble complement inhibitor 1 Interferon-gamma
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Tsuji R F
Noda Institute for Scientific Research, Noda-shi, Chiba-ken 278, Japan.
Geba G P
Wang Y
Kawamoto K
Matis L A
Askenase P W
References (54)
54 references, click to expand
  1. Anti-inflammatory effects and specificity of L-156,602: comparison of effects on concanavalin A and zymosan-induced footpad edema, and contact sensitivity response.
    Immunopharmacology. 1995 Feb;29(1):79-87 PMID: 7768675
  2. The role of the innate immune response in Th1 cell development following Leishmania major infection.
    J Leukoc Biol. 1995 Apr;57(4):515-22 PMID: 7722408
  3. Up-regulation of lung vascular ICAM-1 in rats is complement dependent.
    J Immunol. 1995 Aug 1;155(3):1442-9 PMID: 7636209
  4. Anti-C5 monoclonal antibody therapy prevents collagen-induced arthritis and ameliorates established disease.
    Proc Natl Acad Sci U S A. 1995 Sep 12;92(19):8955-9 PMID: 7568051
  5. Mouse NK1+ T cells.
    Curr Opin Immunol. 1995 Jun;7(3):367-74 PMID: 7546402
  6. An essential role for macrophage migration inhibitory factor in the tuberculin delayed-type hypersensitivity reaction.
    J Exp Med. 1996 Jan 1;183(1):277-82 PMID: 8551232
  7. C3d of complement as a molecular adjuvant: bridging innate and acquired immunity.
    Science. 1996 Jan 19;271(5247):348-50 PMID: 8553069
  8. The instructive role of innate immunity in the acquired immune response.
    Science. 1996 Apr 5;272(5258):50-3 PMID: 8600536
  9. Possible involvement of C5/C5a in the efferent and elicitation phases of contact sensitivity.
    J Immunol. 1996 Jun 15;156(12):4444-50 PMID: 8648091
  10. Mechanism of suppression of cell-mediated immunity by measles virus.
    Science. 1996 Jul 12;273(5272):228-31 PMID: 8662504
  11. Delayed-type hypersensitivity in mast cell-deficient mice: dependence on platelets for expression of contact sensitivity.
    J Immunol. 1996 Jul 15;157(2):557-65 PMID: 8752902
  12. Amelioration of lupus-like autoimmune disease in NZB/WF1 mice after treatment with a blocking monoclonal antibody specific for complement component C5.
    Proc Natl Acad Sci U S A. 1996 Aug 6;93(16):8563-8 PMID: 8710910
  13. Interferon-gamma inducible protein (IP-10) expression is mediated by CD8+ T cells and is regulated by CD4+ T cells during the elicitation of contact hypersensitivity.
    J Invest Dermatol. 1996 Sep;107(3):360-6 PMID: 8751971
  14. The C5a chemoattractant receptor mediates mucosal defence to infection.
    Nature. 1996 Sep 5;383(6595):86-9 PMID: 8779720
  15. Dissection of antigenic and irritative effects of epicutaneously applied haptens in mice. Evidence that not the antigenic component but nonspecific proinflammatory effects of haptens determine the concentration-dependent elicitation of allergic contact dermatitis.
    J Clin Invest. 1996 Sep 1;98(5):1158-64 PMID: 8787679
  16. C5a-dependent up-regulation in vivo of lung vascular P-selectin.
    J Immunol. 1997 Feb 15;158(4):1857-61 PMID: 9029126
  17. Human platelets can initiate T cell-dependent contact sensitivity through local serotonin release mediated by IgE antibodies.
    J Immunol. 1997 Mar 15;158(6):2891-7 PMID: 9058826
  18. The role of complement in inflammation and phagocytosis.
    Immunol Today. 1991 Sep;12(9):322-6 PMID: 1755943
  19. The response of human platelets to activated components of the complement system.
    Immunol Today. 1991 Sep;12(9):338-42 PMID: 1755945
  20. Protective effects of soluble CR1 in complement- and neutrophil-mediated tissue injury.
    J Immunol. 1992 Mar 1;148(5):1479-85 PMID: 1311349
  21. A novel in vivo screening method for immunomodulating substances: development of an assay system.
    Biosci Biotechnol Biochem. 1992 Sep;56(9):1497-8 PMID: 1368956
  22. Preferential suppression of delayed-type hypersensitivity by L-156,602, a C5a receptor antagonist.
    Biosci Biotechnol Biochem. 1992 Oct;56(10):1686-9 PMID: 1369067
  23. Effects of L-156,602, a C5a receptor antagonist, on mouse experimental models of inflammation.
    Biosci Biotechnol Biochem. 1992 Dec;56(12):2034-6 PMID: 1369097
  24. Mouse complement: the effect of sex hormones and castration on two of the late-acting components.
    J Exp Med. 1967 Apr 1;125(4):657-72 PMID: 6020007
  25. Depletion of plasma complement in vivo by a protein of cobra venom: its effect on various immunologic reactions.
    J Immunol. 1970 Jul;105(1):55-69 PMID: 4246566
  26. Augmentation of delayed-type hypersensitivity by doses of cyclophosphamide which do not affect antibody responses.
    J Exp Med. 1975 Mar 1;141(3):697-702 PMID: 1117258
  27. Comparison of the effect of various antisera and cobra venom factor on inflammatory reactions in guinea-pig skin. I. Non-specific inflammation due to the intradermal injection of turpentine.
    J Pathol. 1975 Feb;115(2):97-109 PMID: 1080193
  28. Quantitative studies on cell-mediated immunity in the pleural cavity of guinea-pigs.
    J Pathol. 1975 Oct;117(2):65-73 PMID: 178847
  29. Anaphylatoxins: C3a and C5a.
    Adv Immunol. 1978;26:1-53 PMID: 358800
  30. Molecular aspects of the serum chemotactic factors.
    J Reticuloendothel Soc. 1979 Dec;26(Suppl):711-8 PMID: 522086
  31. Resistance to listeriosis in mice that are deficient in the fifth component of complement.
    Infect Immun. 1980 Jan;27(1):61-7 PMID: 6766905
  32. Platelet-serotonin release by C3a and C5a: two independent pathways of activation.
    J Immunol. 1981 Apr;126(4):1506-9 PMID: 7204973
  33. The structural basis for anaphylatoxin and chemotactic functions of C3a, C4a, and C5a.
    Crit Rev Immunol. 1981 Feb;1(4):321-66 PMID: 7037298
  34. An early component of delayed-type hypersensitivity mediated by T cells and mast cells.
    J Exp Med. 1983 May 1;157(5):1604-17 PMID: 6602201
  35. The role of complement in the induction and regulation of immune responses.
    Immunology. 1984 Feb;51(2):207-24 PMID: 6363279
  36. Regulation of complement protein biosynthesis in mononuclear phagocytes.
    Ciba Found Symp. 1986;118:141-54 PMID: 2426047
  37. Mononuclear phagocytes have the potential to synthesize the complete functional complement system.
    Scand J Immunol. 1988 May;27(5):489-93 PMID: 3287594
  38. A new interpretation of the involvement of serotonin in delayed-type hypersensitivity. Serotonin-2 receptor antagonists inhibit contact sensitivity by an effect on T cells.
    J Immunol. 1989 May 1;142(9):3171-9 PMID: 2785136
  39. The role of IFN-gamma in delayed-type hypersensitivity mediated by Th1 clones.
    J Immunol. 1989 Nov 1;143(9):2887-93 PMID: 2530282
  40. Soluble human complement receptor type 1: in vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis.
    Science. 1990 Jul 13;249(4965):146-51 PMID: 2371562
  41. In vivo inhibition of the antibody response by a complement receptor-specific monoclonal antibody.
    J Exp Med. 1990 Aug 1;172(2):665-8 PMID: 1695671
  42. Synthesis of C3, C5, C6, C7, C8, and C9 by human fibroblasts.
    Scand J Immunol. 1990 Nov;32(5):555-60 PMID: 2270435
  43. Tumor necrosis factor is a critical mediator in hapten induced irritant and contact hypersensitivity reactions.
    J Exp Med. 1991 Mar 1;173(3):673-9 PMID: 1900080
  44. L-156,602, a C5a antagonist with a novel cyclic hexadepsipeptide structure from Streptomyces sp. MA6348. Fermentation, isolation and structure determination.
    J Antibiot (Tokyo). 1991 Feb;44(2):249-54 PMID: 2010362
  45. A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin mu chain gene.
    Nature. 1991 Apr 4;350(6317):423-6 PMID: 1901381
  46. Human umbilical vein endothelial cells synthesize functional C3, C5, C6, C8 and C9 in vitro.
    Scand J Immunol. 1991 Jun;33(6):667-71 PMID: 2047760
  47. Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages.
    Science. 1993 Apr 23;260(5107):547-9 PMID: 8097338
  48. Pentoxifylline suppresses irritant and contact hypersensitivity reactions.
    J Invest Dermatol. 1993 Oct;101(4):549-52 PMID: 8409522
  49. Membrane signaling by complement C5b-9, the membrane attack complex.
    Immunol Res. 1993;12(3):244-57 PMID: 8288945
  50. Soluble recombinant complement receptor 1 inhibits inflammation and demyelination in antibody-mediated demyelinating experimental allergic encephalomyelitis.
    J Immunol. 1994 Jun 1;152(11):5477-84 PMID: 8189065
  51. Inhibitors of serotonin synthesis and antagonists of serotonin 1A receptors inhibit T lymphocyte function in vitro and cell-mediated immunity in vivo.
    J Immunol. 1994 Jul 15;153(2):489-98 PMID: 8021490
  52. C5a-induced expression of P-selectin in endothelial cells.
    J Clin Invest. 1994 Sep;94(3):1147-55 PMID: 7521884
  53. Immunology. Drawing a double-edged sword.
    Nature. 1994 Oct 6;371(6497):474-5 PMID: 7935757
  54. Enhancement by the complement membrane attack complex of tumor necrosis factor-alpha-induced endothelial cell expression of E-selectin and ICAM-1.
    J Immunol. 1995 Aug 1;155(3):1434-41 PMID: 7543521
Article Info
Journal
The Journal of experimental medicine
Abbr.
J Exp Med
ISSN
0022-1007
Published
1997-10-06
Pages
1015-26
Language
English
Region
United States
NLM ID
2985109R
PMCID
PMC2199060
Subset
IM
Grants
NIAID NIH HHS · AI-07174 · United States
NIAID NIH HHS · AI-12211 · United States
NIAID NIH HHS · AI-26689 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]